| |
| |
|
| Insider
Information: |
Springer Timothy A |
| Relationship: |
|
| City: |
Chestnut Hill |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
9,448,471 |
|
|
Indirect Shares
|
4,071,110 |
|
|
| Direct
Value |
$139,260,125 |
|
|
|
Indirect Value
|
$64,583,617 |
|
|
| Total
Shares |
13,519,581 |
|
|
| Total
Value |
$203,843,743 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
15
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
12
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -11.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cartesian Therapeutics, Inc |
RNAC |
Director, 10% Owner |
2024-08-12 |
4,379,899 |
2024-08-12 |
1,939,139 |
Premium* |
|
|
Scholar Rock Holding Corp |
SRRK |
10% Owner |
2019-12-10 |
2,376,567 |
2019-12-10 |
580,855 |
Premium* |
|
|
Morphic Holding, Inc. |
MORF |
|
2024-08-16 |
0 |
2024-08-16 |
0 |
Premium* |
|
|
Tectonic Therapeutic Inc |
TECX |
|
2024-06-20 |
2,692,005 |
2024-06-20 |
1,551,116 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • – |
2016-06-27 |
4 |
A |
$0.00 |
$0 |
I/I |
931,889 |
445,576 |
0 |
- |
|
| SRRK |
Scholar Rock Holding Corp |
Director |
– • • |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,413,945 |
3,202,091 |
0 |
- |
|
| SRRK |
Scholar Rock Holding Corp |
Director |
– • • |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
I/I |
275,903 |
275,903 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
341,686 |
341,686 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,964,962 |
4,565,191 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2019-08-20 |
4 |
A |
$1.81 |
$2,896,000 |
D/D |
1,600,000 |
6,056,597 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2019-08-20 |
4 |
A |
$1.81 |
$1,991,000 |
I/I |
1,100,000 |
1,545,576 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,237,028 |
7,293,625 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2019-12-23 |
4 |
A |
$1.46 |
$5,753,695 |
I/I |
3,940,887 |
5,486,463 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2023-02-13 |
4 |
A |
$35.35 |
$28,499,983 |
I/I |
806,223 |
1,718,464 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2023-02-13 |
4 |
A |
$35.35 |
$1,499,971 |
D/D |
42,432 |
4,607,623 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2023-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
429 |
2,768,893 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • • |
2023-06-28 |
4 |
A |
$0.00 |
$0 |
D/D |
429 |
4,608,052 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2023-11-15 |
4 |
A |
$403.47 |
$9,999,999 |
I/I |
24,785 |
24,785 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2023-11-15 |
4 |
A |
$403.47 |
$49,999,998 |
D/D |
123,925 |
123,925 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
178,000 |
7,471,625 |
0 |
- |
|
| TECX |
Tectonic Therapeutic Inc |
|
– • • |
2024-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,692,005 |
2,692,005 |
0 |
- |
|
| TECX |
Tectonic Therapeutic Inc |
|
– • • |
2024-06-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,551,116 |
1,551,116 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2024-07-02 |
4 |
A |
$20.00 |
$14,453,360 |
I/I |
722,668 |
1,307 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • • |
2024-07-02 |
4 |
A |
$20.00 |
$32,736,640 |
D/D |
1,636,832 |
1,636,832 |
0 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • – |
2016-06-27 |
4 |
B |
$14.00 |
$9,940,000 |
I/I |
710,000 |
1,237,028 |
2.1 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • – |
2017-05-17 |
4 |
B |
$14.01 |
$157,483 |
D/D |
11,244 |
11,244 |
2.39 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • – |
2017-05-18 |
4 |
B |
$14.00 |
$68,040 |
D/D |
4,860 |
16,104 |
2.39 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • – |
2017-06-01 |
4 |
B |
$13.75 |
$7,123 |
D/D |
518 |
16,622 |
2.39 |
- |
|
| RNAC |
Cartesian Therapeutics, I... |
Director |
– • – |
2017-06-27 |
4 |
B |
$17.71 |
$5,999,989 |
D/D |
338,791 |
355,413 |
2.39 |
- |
|
91 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
